Finerenone (non-steroidal MRA), a new treatment option for T2D patients with CKDJadoul, Michel(2022) Webinar Bayer — Location: Online (28.June.2022)
FilesNo attached file found for this publication.DetailsAuthorsJadoul, MichelUCLouvainAuthorAffiliationsUCLouvainSSS/IREC/NEFR - Pôle de NéphrologieUCLouvain(SLuc) Service de néphrologieShow moreCitations APA Chicago FWB Jadoul, M. (2022). Finerenone (non-steroidal MRA), a new treatment option for T2D patients with CKD. Webinar Bayer, Online. https://hdl.handle.net/2078.5/105257